Reisa A Sperling Selected Research

Overweight

1/2016

Lower Late-Life Body-Mass Index is Associated with Higher Cortical Amyloid Burden in Clinically Normal Elderly.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Reisa A Sperling Research Topics

Disease

158	Alzheimer Disease (Alzheimer's Disease) 05/2024 - 04/2005
87	Cognitive Dysfunction 04/2024 - 01/2009
44	Dementia (Dementias) 09/2023 - 03/2009
24	Atrophy 04/2024 - 10/2009
13	Disease Progression 04/2024 - 04/2005
10	Cerebral Cortical Thinning 01/2020 - 03/2009
6	Tauopathies 01/2023 - 10/2016
5	Amyloidosis 12/2023 - 07/2015
5	Amyloid Plaque 11/2023 - 04/2014
5	Proteostasis Deficiencies 09/2021 - 01/2018
3	Edema (Dropsy) 05/2024 - 07/2011
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2022 - 01/2022
2	TDP-43 Proteinopathies 01/2020 - 01/2018
2	Neurobehavioral Manifestations 01/2019 - 06/2011
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 09/2014
2	Agnosia (Visual Agnosia) 01/2017 - 01/2017
1	COVID-19 05/2024
1	Cerebral Hemorrhage 05/2024
1	Headache (Headaches) 05/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2024
1	Hemosiderosis 09/2023
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Carotid Artery Diseases 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Occupational Stress 01/2021
1	Primary Progressive Aphasia 01/2020
1	Amnesia (Dissociative Amnesia) 01/2019
1	Delirium 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019
1	limbic-predominant age-related TDP-43 encephalopathy 01/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2018
1	Hippocampal Sclerosis 01/2018
1	Prodromal Symptoms 01/2018
1	Familial Cerebral Amyloid Angiopathy 01/2016
1	Overweight 01/2016
1	Anhedonia 01/2015
1	Hallucinations (Hallucination) 11/2014
1	Hyperglycemia 09/2014
1	Insulin Resistance 09/2014
1	Memory Disorders (Memory Loss) 04/2014

Drug/Important Bio-Agent (IBA)

118	Amyloid (Amyloid Fibrils)IBA 04/2024 - 03/2009
74	Biomarkers (Surrogate Marker)IBA 04/2024 - 04/2005
20	Amyloid beta-PeptidesIBA 04/2024 - 04/2010
16	Apolipoproteins E (ApoE)IBA 01/2023 - 01/2009
8	Proteins (Proteins, Gene)FDA Link 02/2024 - 06/2012
7	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 02/2024 - 01/2017
7	Presenilin-1IBA 01/2023 - 12/2012
7	ApolipoproteinsIBA 01/2019 - 12/2012
6	Apolipoprotein E4IBA 01/2023 - 01/2013
6	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2019 - 03/2010
6	florbetapirIBA 01/2019 - 10/2012
6	Glucose (Dextrose)FDA LinkGeneric 04/2017 - 06/2011
3	Indicators and Reagents (Reagents)IBA 04/2024 - 11/2012
3	Monoclonal AntibodiesIBA 09/2023 - 04/2010
3	tau Proteins (tau Protein)IBA 01/2022 - 08/2012
3	APTIBA 10/2019 - 12/2015
2	lecanemabIBA 05/2024 - 01/2023
2	HemosiderinIBA 05/2024 - 07/2011
2	Apolipoprotein E3IBA 01/2022 - 11/2019
2	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2020 - 01/2018
2	CholesterolIBA 01/2019 - 01/2015
2	CarbonIBA 01/2019 - 01/2018
1	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2024
1	AnticoagulantsIBA 05/2024
1	Neuroprotective AgentsIBA 04/2024
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2024
1	Prostaglandins FIBA 02/2024
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2024
1	solanezumabIBA 09/2023
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	Threonine (L-Threonine)FDA Link 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	antineoplaston A10 (A 10)IBA 01/2022
1	CytokinesIBA 01/2022
1	Interleukin-12 (IL 12)IBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2021
1	Pemetrexed (MTA)FDA Link 11/2020
1	Cholinergic Agents (Cholinergics)IBA 01/2019
1	HDL LipoproteinsIBA 01/2019
1	oxidized low density lipoproteinIBA 01/2019
1	Scopolamine (Hyoscine)FDA Link 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2018
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 02/2016
1	Dopamine (Intropin)FDA LinkGeneric 02/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	Peptides (Polypeptides)IBA 10/2015
1	chemotactic factor inactivatorIBA 04/2015
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2015
1	HomocysteineIBA 01/2015
1	N2- ((2S)- 2- (3,5- difluorophenyl)- 2- hydroxyethanoyl)- N1- ((7S)- 5- methyl- 6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- L- alaninamideIBA 01/2015
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2014
1	Deoxyglucose (2 Deoxy D glucose)IBA 11/2013
1	Flavin-Adenine Dinucleotide (FAD)IBA 10/2013
1	RadiopharmaceuticalsIBA 01/2013

Therapy/Procedure

17	Activities of Daily Living (ADL) 01/2023 - 01/2011
9	Therapeutics 05/2024 - 04/2005
9	Secondary Prevention 01/2020 - 03/2013